IPO: gold miner Shanjin plans Hong Kong listing amid record prices for precious metal


Shanjin International Gold, one of China’s biggest and most profitable gold miners, is planning a new stock offering in Hong Kong to broaden its financing channels and facilitate its overseas expansion.

The mining group will select an appropriate timing and offering window to complete the listing plan within 24 months after gaining consent from its shareholders, according to a Hong Kong stock exchange filing on late Monday. The plan would require approvals from all regulatory authorities in mainland China and Hong Kong, it added.

Shanjin, whose shares are listed in Shenzhen, was the sixth largest producer and fourth most profitable gold miner based on its 2023 performance, according to the China Gold Association. The company reported a 52.6 per cent jump in net profit to 2.17 billion yuan (US$302.4 million) in 2024, aided by a rally in the precious metal.

Shanjin operates six mines, with three focused on gold production. It acquired a gold exploration and development group, Osino, based in Namibia last year.

Ghana reaches a historic milestone with the opening of its largest gold mine, located in the Talensi district and developed by Shandong Gold. Photo: X/Newsfokus
Ghana reaches a historic milestone with the opening of its largest gold mine, located in the Talensi district and developed by Shandong Gold. Photo: X/Newsfokus

Shandong Gold Mining, a company listed in Hong Kong and Shanghai, controls 29 per cent of Shanjin International and consolidates its results as a “holding subsidiary”. The firm first bought 20.9 per cent of Shanjin in December 2022 and raised its stake to 29 per cent in 2023 from open market purchases.

  • Related Posts

    Singapore property clan puts rare Hong Kong estate up for US$38.4 million tender

    A Singapore-rooted property family has put a rare residential estate in Hong Kong’s Southern district up for tender at about HK$300 million (US$38.4 million), testing demand for trophy homes as…

    Continue reading
    China investors energise Hong Kong biotech stocks. Is foreign money missing out?

    Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *